Stroke

Here's what is coming soon to NeurologyLive.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending December 11, 2020.

Here's what is coming soon to NeurologyLive.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending December 4, 2020.

The research scientist from the University of Texas Medical School at Houston discussed the potential of machine learning to predict outcomes before symptoms arise.

Here's what is coming soon to NeurologyLive.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 27, 2020.

Despite having independent association with a number of outcomes, SVD MRI features lacked prognostic value for patients with stroke.

Here's what is coming soon to NeurologyLive.

The amount of neurofilament light may be indicative of neuron injury in the brain.

Two-thirds of patients with critical results were African American, demonstrating an additional need to explore associations between ethnicity and COVID-19.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 20, 2020.

Machine learning models analyze routine clinical variables to determine the risk of delayed ischemic stroke and other outcomes.

The first trial of tranexamic acid in patients with known ongoing intracerebral hemorrhage shows insignificance compared with placebo, with future studies of simpler recruitment methods needed.

NeurologyLive spoke with Julie Bernhardt, PhD, to learn more about her investigations into developing guidelines for very early mobilization for stroke treatment.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending November 14, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 13, 2020.

A net benefit was observed for all functional outcomes across the entire range of the modified Rankin Scale despite an increased risk of symptomatic intracranial hemorrhage.

The professor of neurology at the NYU Langone Grossman School of Medicine outlined the confusion on whether deaths are related to COVID-19, a symptom associated, or previously unidentified underlying condition.

The professor of clinical neurology at University of Miami and MT2020+ chair discussed the initiative’s effort to improve the global accessibility of mechanical thrombectomy.

The EXTEND and EPITHET trials selected patients by perfusion mismatch rather than the less sensitive noncontrast computed tomography, the findings providing reassurance of consistency for thrombolysis-induced reperfusion.

The vascular neurologist at Memorial Hermann Medical Group discusses how stroke care has been affected throughout the COVID-19 pandemic.

The Mission Thrombectomy 2020+ group outlined a plan to increase the awareness, accessibility, and action for mechanical thrombectomy utilization for patients with stroke globally.

An analysis from English and Scottish stroke centers provides physicians a new view of the trends and outcomes of patients with COVID-19 who experience stroke.